Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

© 2016 Elsevier Inc. All rights reserved. Today considerable effort is undertaken during vaccine development to identify and measure potential mechanisms of immunological protection. These proposed measurements are then validated by correlation with protection from disease after natural exposure or passive protection, or alternatively related to vaccine efficacy or effectiveness endpoints. The desire to identify correlates of protection, especially early in the development of a vaccine, is more than scientific curiosity. The importance of correlates of protection is evident by the reduction of the financial risk associated with clinical development of new vaccines, support of the use of a vaccine in new populations, and the pivotal role in the assessment of the public health impact of vaccines.

Original publication





Book title

The Vaccine Book: Second Edition

Publication Date



121 - 149